Biotechnology Healthcare - November/December 2008 - (Page 36) Introducing the First Generic Epoprostenol Sodium for Injection AP Rated, Bioequivalent and Therapeutically Equivalent to Flolan®* for Injection AP Rated ® lolan * to F An economical choice for your patients Good People, Good Products, Good Chemistry® *Flolan® is a registered trademark of SmithKline Beecham Corp. ©2008, Teva Pharmaceuticals USA 19 Hughes • Irvine, California 92618 800.729.9991 • www.tevausa.com 7988A http://www.tevausa.com http://www.tevausa.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.